Varada Vinay Venkatesh, Panneerselvam Divya, Pushpadass Heartwin A, Mallapa Rashmi Hogarehalli, Ram Chand, Kumar Sachin
Rumen Biotechnology Lab., Animal Nutrition Division, ICAR-National Dairy Research Institute, Karnal, 132001, Haryana, India.
Dairy Engineering Section, ICAR-National Dairy Research Institute, Southern Regional Station, Bengaluru, India.
Curr Res Food Sci. 2023 Apr 22;6:100507. doi: 10.1016/j.crfs.2023.100507. eCollection 2023.
The current study aimed to validate the safety of electrohydrodynamically encapsulated CRD7 and CRD11 in accordance with guidelines of FAO/WHO and ICMR/DBT. assays such as mucin degradation, hemolysis of blood cells, antimicrobial susceptibility pattern, possession of virulence factors, biogenic amine, and ammonia production were assessed. In results, the cross-streak and co-culture techniques revealed that CRD7 and CRD11 were compatible Upon visual inspection through scanning electron and fluorescence microscopy, the integrity of bacterial cell membrane was confirmed even after the encapsulation process. CRD7 and CRD11 were non-hemolytic and showed negative responses to gelatinase, urease, and DNase activities. Non-mucinolytic activity of CRD7 and CRD11 was verified by measuring cell growth rate (p < 0.05) in different modified media followed by SDS-PAGE. High-performance liquid chromatography analysis revealed that both the strains did not produce biogenic amines (putrescine, cadaverine, histamine, and tyramine). Neither of the strains produced ammonia after growing in BHI broth for 5 days at 37 °C. L-lactate production was highest (p < 0.05) in CRD11 (8.83 g/L), followed by CRD7 (8.16 g/L), whereas the lowest (p < 0.05) D-lactate was registered for encapsulated CRD11 (0.33 g/L) and CRD7 (0.49 g/L). The antibiogram profile determined through minimum inhibitory concentration showed that CRD7 and CRD11 were sensitive to key antibiotics suggested by EFSA except for gentamycin and kanamycin. PCR data on virulence genes demonstrated that both strains were safe for probiotic use. Moreover, CRD7 and CRD11 strains caused insignificant (p > 0.05) changes in the cell viability of Caco-2 cells as estimated by MTT (98.94-99.50%) and NR uptake (95.42-97.03%) assays and showed sensitivity to human serum. According to the results of these evaluated attributes, it is concluded that CRD7 and CRD11 are safe, non-toxic to human epithelial cells, and thus may be potentially suitable for various food/feed applications.
本研究旨在根据粮农组织/世界卫生组织以及印度医学研究理事会/生物技术部的指南,验证经电流体动力学封装的CRD7和CRD11的安全性。评估了诸如粘蛋白降解、血细胞溶血、抗菌药敏模式、毒力因子的存在、生物胺和氨的产生等测定。结果显示,交叉划线和共培养技术表明CRD7和CRD11具有兼容性。通过扫描电子显微镜和荧光显微镜目视检查发现,即使在封装过程后,细菌细胞膜的完整性也得到了确认。CRD7和CRD11无溶血现象,对明胶酶、脲酶和DNA酶活性呈阴性反应。通过在不同改良培养基中测量细胞生长速率(p < 0.05)并随后进行SDS-PAGE,验证了CRD7和CRD11的非粘蛋白分解活性。高效液相色谱分析表明,这两种菌株均不产生生物胺(腐胺、尸胺、组胺和酪胺)。在37°C下于脑心浸液肉汤中培养5天后,两种菌株均未产生氨。CRD11中L-乳酸产量最高(p < 0.05)(8.83 g/L),其次是CRD7(8.16 g/L),而封装后的CRD11(0.33 g/L)和CRD7(0.49 g/L)的D-乳酸产量最低(p < 0.05)。通过最低抑菌浓度确定的抗菌谱表明,除庆大霉素和卡那霉素外,CRD7和CRD11对欧洲食品安全局建议的关键抗生素敏感。关于毒力基因的PCR数据表明,这两种菌株作为益生菌使用是安全的。此外,通过MTT(98.94 - 99.50%)和NR摄取(95.42 - 97.03%)测定估计,CRD7和CRD11菌株对Caco-2细胞的细胞活力影响不显著(p > 0.05),并且对人血清敏感。根据这些评估属性的结果,可以得出结论,CRD7和CRD11是安全的,对人上皮细胞无毒,因此可能潜在适用于各种食品/饲料应用。